Alfaro, Merlyn D.

HRN: 01-24-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2026
06/02/2026
IV
2.25g
Q8
CAP HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines